Only two years ago, we had scant evidence that a product used before sex could prevent HIV. Since then, the Caprisa 004 trial has proved that a gel applied topically to the vagina can reduce the chance of HIV infection, and several trials have shown that a tablet taken orally can do the same.
Next on the agenda are rectal microbicide gels and multi prevention technologies designed to prevent pregnancy as well as HIV.
But where does this new technology leave those of us who already have HIV? Adrian Ogier and Jane Costello report from the International Microbicides Conference held in Sydney in April. read more »